Risk factors for loss of skeletal muscle mass in patients with cirrhosis
Ji Hyun Sung, Wasaburo Koizumi(Kitasato University), Tomoaki Fujikawa(Fujisawa City Hospital), Makoto Kako(Shonan Kamakura General Hospital), Takahide Nakazawa(Kitasato University Hospital), Akitaka Shibuya, Hisashi Hidaka(Kitasato University), Naohisa Wada(Kitasato University), Haruki Uojima(National Center for Global Health and Medicine), Kousuke Kubota(Kitasato University), Hiroki Yamanoue(Fukuoka Tokushukai Hospital), Yoshiaki Tanaka(Jichi Medical University)
Cited by 11
Related Papers
Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells.
|Journal of Biological Chemistry|1990|1.5k
KN-62, 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazi ne, a specific inhibitor of Ca2+/calmodulin-dependent protein kinase II.
|Journal of Biological Chemistry|1990|625
N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, a calmodulin antagonist, inhibits cell proliferation.
|Proceedings of the National Academy of Sciences|1981|586
Selective inhibition of catalytic activity of smooth muscle myosin light chain kinase.
|Journal of Biological Chemistry|1987|513
MAPKAP kinase‐2; a novel protein kinase activated by mitogen‐activated protein kinase.
|The EMBO Journal|1992|481